1-2 of 2
Qi Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity

Zeliang Zheng, Ryuhei Okada, Hisataka Kobayashi, Tadanobu Nagaya, Junxia Wei, Qi Zhou, Fred Lee, Tapan K. Bera, Yun Gao, William Kuhlman, Chin-Hsien Tai, Ira Pastan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (3): 812–821.
https://doi.org/10.1158/1535-7163.MCT-19-0890
Published: 02 March 2020
View article titled, Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity
Open the PDF for Site-Specific PEGylation of Anti-Mesothelin Recombinant Immunotoxins Increases Half-life and Antitumor Activity in another window
Includes: Supplementary data
Journal Articles

Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue

Sung Hee Hwang, Antonina Rait, Kathleen F. Pirollo, Qi Zhou, Venkata Mahidhar Yenugonda, Gary M. Chinigo, Milton L. Brown, Esther H. Chang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 559–568.
https://doi.org/10.1158/1535-7163.MCT-07-0548
Published: 17 March 2008
View article titled, Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue
Open the PDF for Tumor-targeting nanodelivery enhances the anticancer activity of a novel quinazolinone analogue in another window